Peptide · Research Monograph · Mitochondrial-derived 16-amino acid peptide

MOTS-c

An 'exercise-mimic' peptide for metabolism and energy

MOTS-c is a peptide produced by our own mitochondria, researched as an 'exercise mimetic' for boosting metabolism, energy, insulin sensitivity, and endurance.

For laboratory research use only — not for human or animal use

Available in the Eon catalog — MOTS-c from $65.00 Certificate of analysis (PDF)

Molecular data

Molecular formulaC101H152N28O25S2
Molecular weight2174.64 Da
SequenceMRWQEMGYIFYPRKLR
Sequence length16 residues
Physical formLyophilized Powder
Available sizes10mg

How it works

AMPK Activation

AMP-Activated Protein Kinase Signaling

MOTS-c activates AMP-activated protein kinase (AMPK) in skeletal muscle, adipose tissue, and liver. AMPK is a master metabolic sensor that responds to cellular energy status. MOTS-c–induced AMPK activation in preclinical models was associated with increased glucose uptake, fatty acid oxidation, and mitochondrial biogenesis signaling.

  • Direct AMPK phosphorylation (Thr172) in skeletal muscle
  • Downstream activation of PGC-1α and mitochondrial biogenesis
  • Enhanced GLUT4 translocation and glucose uptake
mtDNA Origin

Mitochondria-to-Nucleus Retrograde Signaling

MOTS-c is encoded within the 12S rRNA gene of the mitochondrial genome — a discovery that established mitochondria as an endocrine organ capable of producing bioactive peptides. Under metabolic stress, MOTS-c translocates from mitochondria to the nucleus where it acts as a transcriptional regulator, modulating antioxidant response element (ARE) gene expression.

  • Encoded in mitochondrial DNA (12S rRNA gene region)
  • Nuclear translocation under metabolic stress conditions
  • Modulates ARE-driven antioxidant gene expression
Exercise Mimetic

Metabolic Homeostasis & Exercise Signaling

MOTS-c levels naturally rise in response to exercise, and exogenous MOTS-c administration in mouse models replicated several exercise-associated metabolic adaptations including improved insulin sensitivity, reduced adiposity, and increased physical endurance — even in sedentary animals. It inhibits the folate cycle and purine synthesis under stress, redirecting metabolic flux.

  • Endogenous levels increase with aerobic exercise
  • Improves insulin sensitivity in rodent obesity models
  • Inhibits AICAR-independent AMPK activation via folate cycle

What the research shows

Metabolic Research

Insulin Resistance & Obesity

MOTS-c administration in high-fat diet mouse models improved insulin sensitivity, reduced fat accumulation, and normalized glucose tolerance — effects mediated primarily through skeletal muscle AMPK activation.

Lee C et al. 2015

Aging Biology

Age-Related Metabolic Decline

Circulating MOTS-c levels decline with age in both humans and rodents. Exogenous MOTS-c restored age-related declines in physical performance and metabolic flexibility in aged mouse models, suggesting its role in mitochondrial-nuclear communication during aging.

Reynolds JC et al. 2021

Exercise Biology

Exercise Mimicry

Circulating MOTS-c increases significantly with aerobic exercise in humans. In sedentary mouse models, exogenous MOTS-c replicated exercise-related improvements in energy metabolism, mitochondrial biogenesis markers, and physical endurance.

Kim SJ et al. 2022

Longevity Research

mtDNA Variation & Longevity

Population studies identified MOTS-c variants (particularly R150Q) enriched in elderly Japanese populations. Genetic variation in MOTS-c sequence correlates with metabolic disease risk, linking mitochondrial peptide biology to human longevity phenotypes.

Zempo H et al. 2016

Specification

Full NameMitochondrial Open Reading Frame of the 12S rRNA-c
SequenceMRWQEMGYIFYPRKLR
Amino Acids16 residues
Molecular Weight2174.6 Da
Gene OriginMitochondrial 12S rRNA (mt-RNR1)
Primary TargetAMPK activation; folate cycle; nuclear ARE pathways
FormLyophilized powder (5mg)
Purity≥99% (HPLC verified)
TestingThird-party HPLC, Mass Spec, Endotoxin
Storage (lyophilized)-20°C for long-term stability
Storage (reconstituted)2–8°C, use within 30 days
SolubilityBacteriostatic water or sterile saline
COAIncluded with every order

Frequently asked questions

What is MOTS-c and where does it come from?

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome — specifically in the 12S ribosomal RNA gene. Discovered in 2015 by researchers at USC led by Dr. Changhan David Lee, it was one of the first identified mitochondrial-derived peptides (MDPs). Unlike most mitochondrial proteins, MOTS-c is translated from a small open reading frame within non-coding RNA, establishing a new category of regulatory peptides originating from the organelle long considered only a metabolic powerhouse.

How does MOTS-c act as an exercise mimetic?

Circulating MOTS-c levels in humans and rodents increase significantly in response to aerobic exercise. MOTS-c activates AMPK — the same master energy sensor activated by exercise — in skeletal muscle and other metabolic tissues. In preclinical studies, exogenous MOTS-c administration in sedentary mice produced metabolic adaptations similar to exercise training: improved insulin sensitivity, enhanced fatty acid oxidation, increased mitochondrial biogenesis markers, and improved physical endurance. This exercise-mimetic profile has made MOTS-c a subject of significant research interest for metabolic biology.

What is the relationship between MOTS-c and aging?

MOTS-c levels decline with age in both humans and rodents, inversely correlating with age-related metabolic dysfunction. Population genetic studies identified a MOTS-c variant (R150Q, also called K14Q in some notation systems) enriched in elderly Japanese men — suggesting that specific MOTS-c sequences may influence longevity phenotypes. In aged mouse models, exogenous MOTS-c administration partially restored physical performance and metabolic flexibility, positioning it as a candidate for aging biology research.

How does MOTS-c activate AMPK without exercise?

MOTS-c activates AMPK through an indirect mechanism involving the folate cycle. Under metabolic stress, MOTS-c inhibits the enzyme MTHFR (methylenetetrahydrofolate reductase) in the folate-methionine cycle. This disrupts purine nucleotide biosynthesis, causing accumulation of ZMP (5-aminoimidazole-4-carboxamide ribonucleoside monophosphate) — a known AMPK activator. This AICAR-independent pathway for AMPK activation is one of the key mechanistic findings distinguishing MOTS-c from other metabolic peptides.

Are there human studies on MOTS-c?

Human research on MOTS-c primarily consists of observational and correlational studies measuring circulating MOTS-c levels in various populations. These have shown associations between MOTS-c levels and: exercise status, aging, insulin resistance, and cardiovascular disease. Human genetic studies have identified longevity-associated MOTS-c variants. However, no randomized controlled trials of exogenous MOTS-c administration in humans have been completed or published as of 2024.

How should MOTS-c be stored and handled for research?

Store lyophilized MOTS-c at -20°C, protected from light and humidity. Upon reconstitution with bacteriostatic water or sterile saline, aliquot to minimize freeze-thaw cycles and store at 2–8°C, using within 30 days. MOTS-c is water-soluble, making it suitable for aqueous research systems. For cell culture experiments, filter-sterilize solutions before use. Always consult published protocols for concentration-specific guidance.

Literature

  • PubMed The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity 2015 · Lee C et al.
  • PubMed MOTS-c is an exercise-induced mitochondrial encoded regulator of age-dependent physical decline 2021 · Reynolds JC et al.
  • PubMed MOTS-c: A novel exercise-mimetic mitochondrial signal 2022 · Kim SJ et al.
  • PubMed A mitochondrial-encoded peptide in aging and longevity genetic studies 2016 · Zempo H et al.

For laboratory research use only. Not a drug, supplement, or medical product; not for human or animal use. All findings referenced are from published preclinical/laboratory research.